Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: procainamide / niacin attending: addendum: the patient experienced confusion/aggitation on pod#10 prior to discharge. the decision was made to keep the patient in house and adjust medications and evaluate for other sources of confusion. ua was negative. galantamine was increased to home dose, as was effexor. on pod#11 mental status had improved and patient was oriented x 3. bun and crea had improved and he was maintained on lasix 40 iv daily with decrease in peripheral edema. inr was 2.0 and coumadin 1 mg was given with goal inr 1.8-2.5. plan was to evaluate mental status for an additional day and then transfer to rehab. plan of care was discussed with the patient and his wife, who were in agreement. discharge medications include; warfarin 1 mg tablet sig: one (1) tablet po once daily at 4 pm. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). ranitidine hcl 150 mg tablet sig: one (1) tablet po daily (daily). docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). zocor 20 mg tablet sig: one (1) tablet po once a day. bisacodyl 10 mg suppository sig: one (1) suppository rectal daily (daily) as needed for constipation. carvedilol 6.25 mg tablet sig: one (1) tablet po bid (2 times a day). amiodarone 200 mg tablet sig: two (2) tablet po bid (2 times a day): decrease to 400 daily in 1 week then 200 mg x 2 weeks then 200 mg daily then continue as directed by cardiologist. finasteride 5 mg tablet sig: one (1) tablet po daily (daily). risperidone 0.5 mg tablet sig: one (1) tablet po daily daily). polyethylene glycol 3350 17 gram/dose powder sig: one (1) po daily (daily). imatinib 100 mg tablet sig: two (2) tablet po bid (2 times a day). guaifenesin 600 mg tablet sustained release sig: one (1) tablet sustained release po bid (). lasix sig: 40 mg iv intravenous once a day. allopurinol 100 mg tablet sig: one (1) tablet po every other day. venlafaxine 75 mg tablet sig: one (1) tablet po tid (3 times a day). galantamine 4 mg tablet sig: one (1) tablet po bid (2 times a day). labs please check chem 7 and inr daily until stable - inr goal 1.8-2.5 for hx cva and atrial fibrillation discharge disposition: extended care facility: - md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours venous catheterization, not elsewhere classified extracorporeal circulation auxiliary to open heart surgery enteral infusion of concentrated nutritional substances (aorto)coronary bypass of one coronary artery open and other replacement of mitral valve with tissue graft repair of atrial septal defect with tissue graft diagnoses: acidosis hyperpotassemia thrombocytopenia, unspecified anemia, unspecified coronary atherosclerosis of native coronary artery mitral valve disorders acute kidney failure with lesion of tubular necrosis congestive heart failure, unspecified atherosclerosis of aorta personal history of tobacco use depressive disorder, not elsewhere classified other opiates and related narcotics causing adverse effects in therapeutic use atrial flutter chronic kidney disease, stage iii (moderate) other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation ostium secundum type atrial septal defect old myocardial infarction long-term (current) use of anticoagulants abrasion or friction burn of trunk, without mention of infection automatic implantable cardiac defibrillator in situ accidents occurring in other specified places personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits urinary complications, not elsewhere classified acute on chronic systolic heart failure drug-induced delirium bronchiectasis without acute exacerbation epistaxis chronic total occlusion of coronary artery chronic myeloid leukemia, without mention of having achieved remission tricuspid valve disorders, specified as nonrheumatic other diuretics causing adverse effects in therapeutic use hypertensive heart and chronic kidney disease, unspecified, with heart failure and with chronic kidney disease stage i through stage iv, or unspecified 

Answer: The patient is high likely exposed to